MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with T

Theophylline

Theophylline 200mg modified-release tablets

Compatible

Stability notes for Theophylline 200mg modified-release tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Uniphyllin Continus 200mg tablets (Napp Pharmaceuticals Ltd).

Supplier

Uniphyllin 200mg prolonged-release tablets (Ennogen Healthcare International Ltd)

Theophylline 300mg modified-release capsules

No stability information

Stability notes for Theophylline 300mg modified-release capsules

There are no stability notes for this medicine.

Supplier

Theo-24 300mg modified-release capsules (Imported (United States))

Theophylline 300mg modified-release tablets

Compatible

Stability notes for Theophylline 300mg modified-release tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Uniphyllin Continus 300mg tablets (Napp Pharmaceuticals Ltd).

Supplier

Uniphyllin 300mg prolonged-release tablets (Ennogen Healthcare International Ltd)

Theophylline 400mg modified-release tablets

Compatible

Stability notes for Theophylline 400mg modified-release tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Uniphyllin Continus 400mg tablets (Napp Pharmaceuticals Ltd).

Supplier

Uniphyllin 400mg prolonged-release tablets (Ennogen Healthcare International Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.